Hints and tips:
Related Special Reports
...It is the industry’s biggest source of sales, with projected 2028 revenues of $440bn, says data provider IQVIA....
...Gilead has worked with scientists at Accelerated Clinical Trials Ltd to develop a blood cancer treatment....
...The leader of the pack was Teva Pharmaceuticals, whose market capitalisation reached $60bn in 2015. Teva now sits in the crosshairs of law enforcement....
...A Humira biosimilar from Teva Pharmaceuticals working with Alvotech earlier this year became the first drug that the US Food and Drug Administration granted interchangeable status, which lets pharmacists...
...Browns is owned by Sri Lankan holding company LOLC Holdings, whose portfolio spans cars, pharmaceuticals, mining, agriculture and financial services....
...“It was one of the most epic episodes ever in pharmaceuticals history: you got an accelerated approval of a product that didn’t have a completed phase 3 trial....
...The UK pharmaceutical retailer’s transfer of £4.8bn of pension obligations to insurer Legal & General brings its potential sale by owner Walgreens Boots Alliance one step closer....
...The partnership deals follow several others in the industry....
Investor worries about the impact of weight loss drugs on food companies are overdone
...The Swiss canton has a tradition of global commerce, going back to its 19th-century textile industry....
...The closure in April of a big US generics company Akorn Pharmaceuticals and Teva Pharmaceuticals’ decision last month to trim its generics portfolio highlight the extreme pressure the industry is under,...
...Pharmaceutical companies including AstraZeneca and Johnson and Johnson already work with the UK Biobank to access genomic data....
...Initially, the framework will be used to assess the efforts of five companies: Cipla, Hikma, Sun Pharma, Teva and Viatris....
...It also generated excitement across the pharmaceutical industry, which is enticed by the prospect of selling medicines to the more than 50mn people worldwide who suffer from the disease....
...Kirin is expanding its healthcare and pharmaceutical business to diversify away from the domestic beer market, which has shrunk by a third from its 1994 peak....
...A future full of “flying cars” is still in development, but the battle to dominate the industry is well under way, the FT reports....
...In addition to NSO, the Novalpina fund owns the Estonian gambling company Olympic Entertainment Group and the French pharmaceutical business Laboratoire XO....
...That is a step up from current drugs that treat only symptoms: a landmark success in a desert strewn with pharmaceutical failures....
...To make the most of Enhertu’s potential, they are planning 40 trials, one of the largest programmes in the industry....
...A $5bn “sustainability-linked” bond sold by Teva Pharmaceutical Industries on Tuesday was the largest of its kind, but drew immediate questions from some investors about its environmental and social claims...
...Teva declined to comment. Lumen and UltraTech did not respond to a request for comment. *This story has been amended to indicate that Teva is an Israel-based drugmaker....
...The pharmaceutical industry rose to the challenge of Covid-19. But it has largely failed to address the threat posed by antibiotic resistance, which also kills millions....
...And for the pharmaceuticals industry — which is so dependent on intellectual property protection to drive innovation — its findings may represent a line in the sand....
...Michael Sklar, develops “nonstandard trial designs”, which seems to basically use maths to speed up the process of developing pharmaceutical studies....
...It exited its position in generic drugs maker Teva and sold more than 70 per cent of its remaining shares in AbbVie and Bristol-Myers Squibb....
International Edition